AlzeCure Pharma AB (publ) (FRA:AC6)

Germany flag Germany · Delayed Price · Currency is EUR
0.1095
-0.0055 (-4.78%)
At close: Mar 27, 2026
Market Cap17.71M -34.8%
Revenue (ttm)n/a
Net Income-4.40M
EPS-0.04
Shares Outn/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume28
Open0.1095
Previous Close0.1150
Day's Range0.1095 - 0.1095
52-Week Range0.1095 - 0.4370
Betan/a
RSI40.24
Earnings DateApr 8, 2026

About AlzeCure Pharma AB

AlzeCure Pharma AB (publ) operates as a pharmaceutical company that develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is involved in the development of drug candidates based on the NeuroRestore, Alzstatin, and Painless research platforms. Its products pipeline includes ACD856 for the treatment of Alzheimer’s disease, sleep disorders, depression, traumatic brain injuries, and Parkinson’s disease, which is in phase I clinical trial; ACD857, ACD679, and ACD680 that are i... [Read more]

Industry Pharmaceutical Preparations
Founded 2012
Employees 11
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol AC6

Financial Performance

Financial numbers in SEK Financial Statements